David A Mankoff MD
Professor, Radiology, University of Washington School of Medicine
Join to View Full Profile
3400 Spruce StPhiladelphia, PA 19104
Phone+1 215-614-1926
Fax+1 215-349-5843
Dr. Mankoff is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonResidency, Nuclear Medicine, 1992 - 1995- University of WashingtonResidency, Internal Medicine, 1990 - 1992
Perelman School of Medicine at the University of PennsylvaniaClass of 1988
Certifications & Licensure
NJ State Medical License 2014 - 2027
WA State Medical License 1990 - 2027
PA State Medical License 2012 - 2026
American Board of Nuclear Medicine Nuclear Medicine
Awards, Honors, & Recognition
- Komen Scholar Susan G. Komen Foundation
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016
Clinical Trials
- Phase II Trial of 64Cu-ATSM PET/CT in Cervical Cancer Start of enrollment: 2009 Jul 29
- MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2009 Aug 24
- Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases Start of enrollment: 2009 Sep 01
Publications & Presentations
PubMed
- [ 18 F]Fluoroestradiol Uptake in Benign Nodular Sclerosing Adenosis of the Breast.Ismaheel O Lawal, Rebecca Seidel, Xiaoxian Li, Jemimah Nayar, David A Mankoff
Clinical Nuclear Medicine. 2026-08-01 - Response to the Comment on "Negative 18 F-FES PET/CT Despite Estrogen Receptor Positivity By Immunohistochemistry."Ismaheel O Lawal, David A Mankoff, David M Schuster
Clinical Nuclear Medicine. 2026-08-01 - Navigating the path: Advice to physician-scientists on choosing a clinical specialty.Talia Swartz, Jose E Cavazos, Marshall Horwitz, Patrick J Hu, Barbara Sampson
Elife. 2026-07-03
Journal Articles
- Test-Retest Reproducibility of FDG-PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local NetworkJennifer M Specht, Jean H Lee, Hannah M Linden, Andrew T Shields, David A Mankoff, Paul E Kinahan, Journal of Nuclear Medicine
- Glutamate-Weighted Chemical Exchange Saturation Transfer Magnetic Resonance Imaging (GluCEST MRI) Detects Glutaminase Inhibition in a Mouse Model of Triple-Negative Br...Ravinder Reddy, David Mankoff, Clinical Cancer Research
Press Mentions
What 17 Leaders Wish Medical Students Learned About Cancer CareSeptember 10th, 2025- GE HealthCare Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)May 24th, 2023
- How One Doctor-Patient Relationship Could Change How Women Are Treated for Gynecologic CancersFebruary 2nd, 2023
Grant Support
- Translational Imaging Markers for Metabolic Potentiation of ImmunotherapyUNIVERSITY OF PENNSYLVANIA2026–2031
- Research Track Radiology ResidencyUNIVERSITY OF PENNSYLVANIA2005–2030
- PET Imaging of Glutamine Metabolism and Glutamate Transport to Guide Metabolically Targeted Therapy in Triple-Negative Breast CancerUNIVERSITY OF PENNSYLVANIA2022–2027
- Breast Cancer PARP PET Imaging AIP to Support FDA Approval & CommercializationUNIVERSITY OF PENNSYLVANIA2021–2026
- Advanced PET/CT Imaging For Improving Clincail TrialsNational Cancer Institute2010–2012
Professional Memberships
- Society of Nuclear Medicine and Molecular ImagingMember
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
